BMRN vs BNED · P/E 40, rev $1.76B vs rev $1.71B
Biomarin Pharmaceutical Inc (BMRN) versus Barnes & Noble Education Inc (BNED) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Barnes & Noble Education Inc (BNED) is a specialty retail company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported BNED revenue for 2026-05-02 was $1.71B. Net income was $16.9M. Revenue was up 508.5% from 2025-05-03 to 2026-05-02. BNED currently screens at market cap $390.9M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. BNED currently screens at market cap $390.9M.
Not investment advice. Open the BMRN and BNED stock pages for the full models.
Not investment advice.